Are the effects of cholesterol lowering drugs always equal? [20]

Lancet

Volumn 347, Issue 9010, 1996, Pages 1267-1268

  Vandenbroucke, J P ^a   Westendorp, R G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CORONARY RISK; HEART INFARCTION; LETTER; MEDICAL DECISION MAKING; METHODOLOGY; PRIORITY JOURNAL;

EID: 0029940539     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90790-4     Document Type: Letter

References (4)

1. Scandinavian Simvastatin Survival Study Group Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) Lancet 345 1995 1274 1275
2. J. Shepherd Sm Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
3. Dl Sackett Rb Haynes Gh Gyatt P. Tugwell 2nd Clinical epidemiology: a basic science for clinical medicine 1991 Little, Brown and Co Boston 205-07
4. Kj Rothman Modern epidemiology 1986 Little, Brown and Co Boston 311-26